SRXH

SRX Health Solutions, Inc.

SRXH

Market cap $12M

Overview Fund Activity

0.3600 USD

+0.0540

17.65%

At close Updated Sep 15, 4:00 PM EDT

Pre-market

After hours

0.3580

-0.0020

0.56%

1 day

17.65%

5 days

7.46%

1 month

-28%

3 months

-38.12%

6 months

-69.23%

Year to date

-78.95%

1 year

-82.35%

5 years

-99.73%

10 years

-99.73%

About: SRX HealthSolutions Inc is an integrated, Canadian healthcare service provider operating within the specialty healthcare industry. It has developed a collaborative specialty healthcare network (the SRx Network) that strategically positions SRx to achieve business objectives. The SRx Network is comprised of 29 specialty pharmacies, 40 infusion clinics and injection sites, four clinical trials sites, patient support programs (PSP), an allied health team and nursing services, and a wholly owned Health Canada-accredited pharmaceutical wholesale and distribution facility located in Mississauga, Ontario. The SRx Network extends across all 10 Canadian provinces, making it one of the accessible providers of comprehensive, integrated and customized specialty healthcare services in Canada.

Consumer Staples Beverages - Non-Alcoholic

0

Funds holding %

of 7,463 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

167% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 3

45% more funds holding

Funds holding: 11 [Q1] → 16 (+5) [Q2]

3.24% less ownership

Funds ownership: 4.24% [Q1] → 1.0% (-3.24%) [Q2]

35% less capital invested

Capital invested by funds: $107K [Q1] → $69.9K (-$37.1K) [Q2]

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

See Fund Rankings

Financial journalist opinion

Based on 3 articles about SRXH published over the past 30 days

SRx Health Solutions Cancels an Additional 350,000 Shares, Increasing the Total Number of Shares Canceled to Over 19 Million

All legal options remain under consideration regarding the actions of former SRx Canada officers All legal options remain under consideration regarding the actions of former SRx Canada officers

SRx Health Solutions Cancels an Additional 350,000 Shares, Increasing the Total Number of Shares Canceled to Over 19 Million

SRx Health Solutions Announces Receipt of Late Filing Notification Letter from NYSE American

TAMPA, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced that on August 20, 2025, it received an official notice from NYSE Regulation indicating that the Company is not in compliance with the continued listing standards of NYSE American LLC (the “Exchange”) as set forth in Section 1007 of the NYSE American Company Guide. The notice was issued because the Company did not timely file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 (the “Delinquent Report”) with the Securities and Exchange Commission (the “SEC”) by the required due date of August 19, 2025.

SRx Health Solutions Announces Receipt of Late Filing Notification Letter from NYSE American

SRx Health Solutions Signed a Letter of Intent to Acquire the Assets of Royal Uranium

TAMPA, Fla., Aug. 18, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (“SRx Health” or the “Company”), a leading global health and wellness company, today announced that is has signed a non-binding Letter of Intent to purchase 100% of the assets of Royal Uranium Inc., a leading uranium royalty business with a portfolio spanning Canada, Colombia, Argentina and Namibia.

SRx Health Solutions Signed a Letter of Intent to Acquire the Assets of Royal Uranium

SRx Health Solutions Announces the Cancellation of Approximately 18.8 Million Shares of its Capital Stock

The Company intends to explore all available legal remedies against former officers of SRx Canada The Company intends to explore all available legal remedies against former officers of SRx Canada

SRx Health Solutions Announces the Cancellation of Approximately 18.8 Million Shares of its Capital Stock

SRx Health Solutions Obtains Initial Order under CCAA for its Canadian Subsidiary

TAMPA, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced that its subsidiary, SRx Health Solutions (Canada), Inc.(“SRx Canada”) and certain of its subsidiaries obtained an Initial Order (the “Initial Order”) in Canada under the federal Companies' Creditors Arrangement Act (the “CCAA” and SRx Canada's proceedings thereunder, the “CCAA Proceedings”) from the Ontario Superior Court of Justice (Commercial List) (the “Court”).

SRx Health Solutions Obtains Initial Order under CCAA for its Canadian Subsidiary

SRx Health Solutions Announces Management and Board Changes

TAMPA, Fla., July 15, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced the appointment of current President, Kent Cunningham, as CEO, and current CEO, Adesh Vora, as Vice Chairman effective immediately.

SRx Health Solutions Announces Management and Board Changes

SRX Health Completes $7.3 Million Financing Led by Insiders and Existing Investors and Announces Financial Commitment of Up to $50 Million

TAMPA, Fla., July 08, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (“SRX Health” or the “Company”), a leading global health and wellness company, today announced the successful closing of a $7.3 million convertible note financing, led by insiders and existing investors. Additionally, SRX Health has secured a $50 million equity line of credit (‘ELOC'). This financing and ELOC financial commitment significantly strengthens the Company's balance sheet and provides additional working capital to advance near-term growth initiatives.

SRX Health Completes $7.3 Million Financing Led by Insiders and Existing Investors and Announces Financial Commitment of Up to $50 Million

SRx Health Solutions Announces Management and Board Changes

TAMPA, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced the following management team and Board of Directors changes. Lionel Conacher, current Board member, has been appointed as Chairman of the Board, Adesh Vora, current Executive Chairman, will remain on Board and be appointed Chief Executive Officer, Kent Cunningham, current Chief Executive Officer, will assume role as President, and Nina Martinez has been appointed Chief Financial Officer.

SRx Health Solutions Announces Management and Board Changes

SRx Health Solutions Further Diversifies Treasury Strategy with Purchase of Ethereum

TAMPA, Fla., May 16, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced further diversifying its treasury strategy with the purchase of Ethereum (ETH). The Company has sold its ownership of $1.5 million of Solana Tokens (SOL).

SRx Health Solutions Further Diversifies Treasury Strategy with Purchase of Ethereum

SRx Health Solutions Announces First Quarter 2025 Financial Results

EPS Improved 90% Year-Over-Year to $(0.37) Adjusted EBITDA 1 Loss Improved 54% Year-Over-Year to $(0.6) Million Adjusted EBITDA Margin 1 Improved (9)% , a 865 Basis Point Expansion Year-Over-Year TAMPA, Fla., May 15, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions Inc. (NYSE American: SRXH) (the “Company” or "SRx", previously known as “Better Choice”), a leading global health and wellness company, today announced its results for the first quarter ended March 31, 2025.

SRx Health Solutions Announces First Quarter 2025 Financial Results

See News Rankings

Charts implemented using Lightweight Charts™